owing to "many vectors for growth that’s not yet reflected in valuation and the shareholder base." Analyst Michael Cyprys sees a particular opportunity for Robinhood (NASDAQ:HOOD) to beef up its ...
The global viral vectors for non-human primates market was valued at USD 145.8 Mn in 2023 and is projected to grow at a CAGR ...
2024 Performance: 2024 GMV and revenue come in both in the upper half of the guidance, with 4.5% and 4.2% growth, respectively. Adjusted EBIT reaches 511 million euros, up from 350 million euros a ...